Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
about
Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-AnalysisAlogliptin benzoate for management of type 2 diabetesAddition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysisComparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic reviewCardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials.Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients.Analyzing the Factors Contributing to Withdrawal from Insulin Therapy Following Additional Administration of Alogliptin: Retrospective Study after Removing Glucotoxicity with Insulin.Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis.Application of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptinThe pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.Alogliptin benzoate for the treatment of type 2 diabetes.Alogliptin: a review of its use in patients with type 2 diabetes mellitus.Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation.Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions.A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control.Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, pl
P2860
Q28071764-EA8A2592-55AE-4AD9-AEE7-84B205527A32Q28083933-9D522E71-2BA3-4181-A990-D0FD13498894Q28275281-58A9A9E8-848A-4B19-BC04-BF56B90108EFQ28540671-2121103D-9A5A-497A-8852-EC45F07A4E75Q30240823-CA4B6FD7-8903-46DA-9A20-D804F6F9166DQ34299664-9B1799CA-6355-4CD9-BEE3-0B8D919D1004Q36082398-6BFDF3C9-1DF1-4DF7-8C1F-4BF5469C3853Q36124544-CEC1FC1B-B539-4836-A9EE-39555DDBBFE6Q36706802-3C29F00F-6D38-499A-88F7-5C9E9E5D4D8AQ37639487-522A8897-E826-4B81-9459-518DB75F4E29Q38197275-545ECD2D-99DD-46D9-990A-E868AF2C52E8Q38412153-718279D8-CBC2-441A-8128-CF333DBAFF8CQ38647717-2D90F30B-7670-4D8E-ADE8-B67BE28A0B31Q38795046-978CB160-7E50-4E7C-95D9-558239E5E8C9Q41259354-D0BC7381-C76A-4E30-8E93-9B3931333951Q51233383-A5FFB269-EC23-4A23-8E3A-FAA3457E5683
P2860
Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Efficacy and safety of aloglip ...... bel, long-term extension study
@ast
Efficacy and safety of aloglip ...... bel, long-term extension study
@en
Efficacy and safety of aloglip ...... el, long-term extension study.
@nl
type
label
Efficacy and safety of aloglip ...... bel, long-term extension study
@ast
Efficacy and safety of aloglip ...... bel, long-term extension study
@en
Efficacy and safety of aloglip ...... el, long-term extension study.
@nl
prefLabel
Efficacy and safety of aloglip ...... bel, long-term extension study
@ast
Efficacy and safety of aloglip ...... bel, long-term extension study
@en
Efficacy and safety of aloglip ...... el, long-term extension study.
@nl
P2093
P2860
P1476
Efficacy and safety of aloglip ...... bel, long-term extension study
@en
P2093
Kohei Kaku
Masashi Hirayama
Shinzo Hiroi
Yutaka Seino
P2860
P304
P356
10.1111/J.2040-1124.2012.00226.X
P577
2012-07-12T00:00:00Z